Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.
Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China.
J Ethnopharmacol. 2017 Jul 31;207:92-99. doi: 10.1016/j.jep.2017.05.034. Epub 2017 May 31.
Baeckea frutescens L. is commonly used as a folk medicinal material. There are nineteen components in its volatile oil, including Pcymol which has effects of eliminating phlegm, relieving asthma and antiviral. This study was aimed to investigate the anti-infectious inflammatory activities of Baeckea frutescens L. and its conponents and analyzing the mechanisms.
The anti-infectious inflammation of Baeckea frutescens L. were studied by using macrophage activating lipopeptide-2 (MALP-2)-stimulated RAW264.7 cell model in vitro. Secretion of nitric oxide (NO), expression of inducible NO synthase (iNOS) and cytokines were detected as classic inflammatory index. Expression of Myeloid differentiation factor 88 (MyD88), degradation of inhibitory κBα (IκBα) and nuclear translocation of NF-κB p65 were further investigated.
The results suggested that Baeckea frutescens L. has effect on suppression of MALP-2-mediated inflammation in RAW264.7 cells. The secretion of NO and the expression of iNOS could be inhibited. The secretion of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) were also declined. Baeckea frutescens L. significantly decreased the expression of MyD88, therefore, inhibited the degradation of IκBα, reduced the level of nuclear translocation of p65.
The results of this study indicated that Baeckea frutescens L. and its components could inhibit the anti-infectious inflammatory events and iNOS expression in MALP-2 stimulated RAW264.7 cells. Among them, BF-2 might play a role through the inhibition of the MyD88 and NF-κB pathway. Our study might provide a new strategy to design and develop this kind of drug towards mycoplasma-infected inflammation.
山芝麻(Baeckea frutescens L.)常被用作民间药材。其挥发油含有 19 种成分,其中包括具有祛痰、平喘和抗病毒作用的对伞花烃。本研究旨在探讨山芝麻的抗感染炎症活性及其成分,并分析其机制。
采用巨噬细胞激活脂肽-2(MALP-2)刺激 RAW264.7 细胞体外模型研究山芝麻的抗感染炎症作用。一氧化氮(NO)的分泌、诱导型一氧化氮合酶(iNOS)的表达和细胞因子的表达作为经典炎症指标进行检测。进一步研究髓样分化因子 88(MyD88)的表达、抑制κBα(IκBα)的降解和 NF-κB p65 的核转位。
结果表明,山芝麻对 MALP-2 介导的 RAW264.7 细胞炎症有抑制作用。NO 的分泌和 iNOS 的表达均可被抑制。肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)的分泌也下降。山芝麻显著降低了 MyD88 的表达,从而抑制了 IκBα的降解,降低了 p65 的核转位水平。
本研究结果表明,山芝麻及其成分可抑制 MALP-2 刺激的 RAW264.7 细胞抗感染炎症反应和 iNOS 表达。其中 BF-2 可能通过抑制 MyD88 和 NF-κB 通路发挥作用。本研究为设计和开发针对支原体感染炎症的这类药物提供了新策略。